Neurology News

Viz.ai announced a collaboration with BIOS Clinical Trials Coordinating Center at Johns Hopkins University to facilitate patient enrollment for the NIH-funded Biomarker and Edema Attenuation in Intracerebral Hemorrhage study.

Linus Health announced a collaboration with Goizueta Institute @Emory Brain Health and The Seavey Clinic at Emory Healthcare to implement digital cognitive assessments in primary care for early detection of Alzheimer’s disease.

Our third and final post in the series “Introduction to Taxation of Sales Proceeds” addresses the taxation of sale proceeds if a target practice is a partnership, including an LLC treated as a partnership.

CN Diagnostics announced it has received a $15 million program-related investment from GHR Foundation to support and advance the PrecivityAD2 blood test for the detection of Alzheimer’s disease.

Teva Pharmaceuticals announced FDA approval of Austedo XR, a once-daily, extended-release formulation for adults with tardive dyskinesia and chorea associated with Huntington’s disease.

A virtual reality exercise session might be as effective as telehealth-delivered exercise sessions in providing immediate, short-term pain relief for people with endometriosis, according to study results.

Ashvattha Therapeutics announced that the first patient has been enrolled in a phase 1/2 study to evaluate the ability of an imaging agent to cross the blood-brain barrier and target key markers of neuroinflammation.

Medical technology company Imperative Care has announced the formation of Kandu Health, a digital health startup that aims to advance stroke recovery and post-acute stroke care through education, resources and guidance.

Long-term exposure to air pollutants may be associated with increased readmissions after ischemic stroke, according to data published in Stroke.

Nova Mentis Life Science Corp. has received an exemption under Section 56 of the Health Canada Controlled Drugs and Substances Act to advance a phase 2a clinical trial examining oral microdose psilocybin therapy for fragile X syndrome.